Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.180
0.00 (0.00%)
At close: Feb 13, 2026
Market Cap1.77B +1.0%
Revenue (ttm)1.22B +3.2%
Net Income193.37M -68.7%
EPS0.13 -68.7%
Shares Out1.50B
PE Ratio9.19
Forward PEn/a
Dividend0.06 (5.34%)
Ex-Dividend DateSep 16, 2025
Volume196,000
Average Volume286,750
Open1.180
Previous Close1.180
Day's Range1.160 - 1.190
52-Week Range1.070 - 1.470
Beta0.20
RSI48.05
Earnings DateMar 25, 2026

About HKG:2348

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates through two segments, Intermediates and Bulk Medicines; and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics. It also provides system specific medicines comprising cardiovascular systems; anti-HBV, anti-all... [Read more]

Sector Healthcare
Founded 1995
Employees 1,116
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2348
Full Company Profile

Financial Performance

In 2024, HKG:2348's revenue was 1.06 billion, a decrease of -7.89% compared to the previous year's 1.15 billion. Earnings were 564.94 million, an increase of 73.29%.

Financial numbers in CNY Financial Statements